Global Immunohistochemistry Transmitter Markers Market – Industry Trends and Forecast to 2029

Market Analysis and Size

Over the past few years, there has been increasing implementation of automation and machine learning in immunohistochemistry (IHC), due to which the market has been growing largely and is expected to continue the same pace of the growth within the forecasted period. Moreover, the market is being propelled forward and is expected to expand within the period as there are continuous introduction of technologically advanced immunohistochemistry solutions within the market which push the market towards the growth.

• Data Bridge Market Research analyses that the immunohistochemistry transmitter markers market is expected to grow at a CAGR of 4.7% during the forecast period. The “antibodies” accounts for the largest type segment in the immunohistochemistry transmitter markers market within the forecasted period.

Market Definition

The immunohistochemistry transmitter markers market deals with the product immunohistochemistry transmitter markers. Immunohistochemistry (IHC) is a technique that uses the principle of antibodies binding specifically to antigens in biological tissues to detect antigens or haptens in cells of a tissue section. Immunohistochemical markers are proteins that aid doctors in distinguishing between various cancer types.

Immunohistochemistry Transmitter Markers Market Dynamics

Drivers

• Growing Targeted Diseases

The increasing cases of cancer along with the subsequent growth in prevalence of chronic and infectious diseases across the globe is the most significant factor driving the growth for this market.

The increasing geriatric population and the growing number of diagnostic centers are projected to cushion he growth of the market. Moreover, the rising awareness amongst the consumers regarding the caner and increasing healthcare spending are also expected to fuel market growth. Moreover, the growing demand for the personalized medicine also cushions the market’s growth within the forecasted period.

Opportunities

Furthermore, the growing investments flow by the pharmaceutical companies and the biotechnology companies in research and development activities of novel drug discovery and development extends profitable opportunities to the market players in the forecast period of 2022 to 2029. Moreover, advancements and innovations in the healthcare industry such as emergence of various advanced techniques, such as multiplex IHC, computational pathology and next-generation IHC will further expand the immunohistochemistry transmitter markers market's growth rate in the future. 

Restraints/Challenges

On the other hand, limited refund policies is expected to obstruct market growth. Also, the high degree of consolidation in the by the major market players are projected to challenge the immunohistochemistry transmitter markers market in the forecast period of 2022-2029.

This immunohistochemistry transmitter markers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the immunohistochemistry transmitter markers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Immunohistochemistry Transmitter Markers Market

The immunohistochemistry transmitter markers market has been highly impacted by the COVID-19. The government's various strict guidelines and regulations regarding social distancing and movement restrictions had a negative impact on the market. However, the key market players are taking steps to address the pandemic's challenges. Several key players have shifted their business focus to COVID-19 research by introducing IHC products.

Recent Developments

• In August 2021, Roche's VENTANA MMR RxDx Panel has been approved by the FDA to identify dMMR solid tumour patients who are candidates for anti-PD-1 immunotherapy.
• In August 2021, Agilent's PD-L1 IHC 22C3 pharmDx assay for identifying oesophageal cancer patients for treatment with KEYTRUDA received a CE-IVD mark in Europe.
• In March 2021, The DISCOVERY Green HRP kit from Roche was developed to detect and profile biomarkers and cell populations in tissue-based research. This kit can be used in conjunction with other detection kits to increase the in situ hybridization and immunohistochemistry multiplexing capacity.

Global Immunohistochemistry Transmitter Markers Market Scope

The immunohistochemistry transmitter markers market is segmented on the basis of product, protein detection, application and end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Antibodies
• Equipment
• Reagents

On the basis of product, the immunohistochemistry transmitter markers market is segmented into antibodies, equipment and reagents. The antibodies is sub-segmented into primary antibodies and secondary antibodies. The equipment is sub-segmented into slide staining systems, tissue microarrays, tissue processing systems, slide scanners and others. The reagents is sub-segmented into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers and others. Antibodies are projected to be the largest segment within the product segment within the forecast period.

Protein Detection

• Cytokeratins, Vimentin
• Leukocyte Common Antigen
• CD20
• CD34
• Smooth Muscle Actin
• Desmin
• S- 100
• HMB- 45

On the basis of protein detection, the immunohistochemistry transmitter markers market is segmented into cytokeratins, vimentin, leukocyte common antigen, CD20, CD34, smooth muscle actin, desmin, S- 100 and HMB- 45.

Application

• Diagnostics
• Drug Testing

On the basis of application, the immunohistochemistry transmitter markers market is segmented into diagnostics and drug testing. The diagnostics is sub-segmented into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus and others. Diagnostics dominates the application segment as it is estimated to register the highest growth during the forecast period.

End-Users

• Hospitals and Diagnostics Centers
• Research Institutes
• Other End- Users

On the basis of level of end users, the immunohistochemistry transmitter markers market is segmented into hospitals and diagnostics centers, research institutes and other end- users.

Immunohistochemistry Transmitter Markers Market Regional Analysis/Insights

The immunohistochemistry transmitter markers market is analysed and market size insights and trends are provided by country, product, protein detection, application and end-users as referenced above.

The countries covered in the immunohistochemistry transmitter markers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the immunohistochemistry transmitter markers market because of the high prevalence of cancer and other chronic diseases in the region, increase in the number of research partnerships and the established healthcare infrastructure drives the growth of the immunohistochemistry transmitter markers market within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rapidly increasing geriatric population, rising prevalence of chronic ailments, growing academic and government investments in diagnostic research and the presence of many market players within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The immunohistochemistry transmitter markers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immunohistochemistry transmitter markers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunohistochemistry transmitter markers market. The data is available for historic period 2010-2020.

Competitive Landscape and Immunohistochemistry Transmitter Markers Market Share Analysis

The immunohistochemistry transmitter markers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to immunohistochemistry transmitter markers market.

Some of the major players operating in the immunohistochemistry transmitter markers market are Sino Biological Inc., BioGenex, Bio SB, Cell Signaling Technology, Inc., Abcam plc, PerkinElmer Inc., Agilent Technologies, Inc., Merck KGaA, F. Hoffmann-LA Roche AG, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Perkinelmer, Inc., and Cell Signaling Technology, Inc., among others.

SKU-52374